Cardinal Health Inc. raised its full-year profit projections by 20 cents per share after beating expectations in the fourth ...

Elizabeth Warren seeks scrutiny of deals that would allow drug middlemen McKesson, Cardinal Health, and Cencora to also ...

A Relative Strength Rating upgrade for Cardinal Health shows improving technical performance. Will it continue?

Illinois will receive a $40 million share of a $1.4 billion bipartisan national settlement with Kroger over the grocery chain ...

Cardinal Health's Q1 2025 earnings reaffirm my buy rating due to a strengthening pharmacy business and industry tailwinds.

Leerink Partners analyst Michael Cherny has reiterated their bullish stance on CAH stock, giving a Buy rating yesterday. Michael Cherny has ...

Cardinal Health raised its fiscal 2025 adjusted profit forecast on Friday as strong demand for costly specialty medicines and branded drugs drove sales at its pharmaceuticals unit, sending shares of ...

Drug distributor Cencora plans to buy Retina Consultants of America from Webster Equity Partners in a $4.6 billion deal.  | ...

In a report released on November 1, Erin Wright from Morgan Stanley maintained a Buy rating on Cardinal Health (CAH – Research Report), ...

Cardinal Health's pharmaceutical and specialty solutions segment contributed to the company's strong performance in the first quarter, leading the Dublin, Ohio-based company to raise its fiscal ...

Greater use of obesity drugs and other pricey medicines helped spur Cardinal Health to a fiscal first-quarter earnings beat, boosting its share price as well as competing drug distributors. Cardinal ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...